Crossmark

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3

Published Print: 2016-03

Authors

Mazzanti, Andrea

Maragna, Riccardo

Faragli, Alessandro

Monteforte, Nicola

Bloise, Raffaella

Memmi, Mirella

Novelli, Valeria

Baiardi, Paola

Bagnardi, Vincenzo

Etheridge, Susan P.

Napolitano, Carlo

Priori, Silvia G.
License Information

Text and Data Mining valid from 2016-03-01

Version of Record valid from 2017-03-08
More Information

This article is maintained by: Elsevier

Article Title: Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3

Journal Title: Journal of the American College of Cardiology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacc.2015.12.033

Content Type: article

Copyright: Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Document is current